Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety (Q46661382)
scientific article
Language:
(P31) (Q13442814)
(P304) 31-38
(P407) (Q1860)
(P433) 1
(P478) 299
(P577) Monday, October 1, 2001
(P921) (Q323936)
(Q14599311)
(P1433) (Q1500272)
(P1476) "Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety" (language: en)
(P2093) Kelley SK
Harris LA
Xie D
Deforge L
Totpal K
Bussiere J
Fox JA
other details
description scientific article

External Links